CVS Health, Illumina Rise Premarket; Bed Bath & Beyond, Brigham Minerals Fall By Investing.com


© Reuters

By Peter Nurse

Investing.com — Stocks in focus in premarket trade on Tuesday, September 6th. Please refresh for updates.

  • CVS Health (NYSE:) stock rose 1.5% after agreeing to buy home healthcare services company Signify Health (NYSE:), down 0.1%, for about $8 billion in cash, a move that will enable one of the largest U.S. healthcare companies to provide further care management to patients in their homes.

  • Bed Bath & Beyond (NASDAQ:) stock slumped 15.1% after the suicide of the troubled retailer’s chief financial officer on Friday, days after it announced it was closing stores and laying off workers.

  • Illumina (NASDAQ:) stock rose 4% after the European Union blocked the biotech company’s $7.1 billion acquisition of cancer detection test maker Grail on antitrust grounds.

  • Tesla (NASDAQ:) stock rose 0.9% after Wolfe Research upgraded its investment stance on the electric car manufacturer to ‘outperform’ from ‘peer perform’, saying it can rise 30%, benefitting from the Inflation Reduction Act.

  • Brigham Minerals (NYSE:) stock fell 3.1% after the Wall Street Journal reported that it was set to merge with Sitio Royalties (NASDAQ:), down 1.7%, in one of the largest deals in the oil-and-gas industry this year.

  • Anheuser Busch Inbev (NYSE:) ADRs rose 2.4% after HSBC upgraded its stance on the brewer to ‘buy’ from ‘hold’, saying the stock can surge 30% on the strength of its premium brands.

  • Digital World Acquisition Corp (NASDAQ:) stock tumbled 21% after Reuters reported the blank-check acquisition firm that agreed to merge with Donald Trump’s social media company failed to secure enough shareholder support for an extension to complete the deal.

Be the first to comment

Leave a Reply

Your email address will not be published.


*